Treatment

Smoking cessation is essential, and pulmonary rehabilitation may improve quality of life and functional capacity for patients with any ILD. Pharmacologic options include single-agent or combination corticosteroid therapy and immunomodulating or antifibrotic agents (azathioprine, cyclophosphamide, colchicine, D-penicillamine). Overall, these therapies have shown marginal to no benefit in cases

Figure 18-11 Computed tomographic scan of a patient with idiopathic pulmonary fibrosis.

of idiopathic pulmonary fibrosis, whereas patients with other ILDs may have a better response (Davies et al., 2003). A meta-analysis of 390 patients with pulmonary fibrosis did find that interferon gamma-1b therapy significantly reduced mortality (Bajwa et al., 2005). Causes of death identified for pulmonary fibrosis in one study included respiratory failure (39%), cardiovascular disease (27%), lung cancer (10%), pulmonary infection or emboli (6%) (Panos, 1990).

Unilateral lung transplantation may enhance survival and functioning in patients with advanced interstitial fibrosis with chronic respiratory failure, whereas pulmonary fibro-sis with pulmonary hypertension may require bilateral lung transplantation (Alalawi et al., 2005). One-year survival after lung transplantation is 75%, with 44% of patients surviving 5 years or longer (Trulock, 2001).

Quit Smoking For Good

Quit Smoking For Good

Quit smoking for good! Stop your bad habits for good, learn to cope with the addiction of cigarettes and how to curb cravings and begin a new life. You will never again have to leave a meeting and find a place outside to smoke, losing valuable time. This is the key to your freedom from addiction, take the first step!

Get My Free Ebook


Post a comment